Oaktree Acquisition Corp. III Life Sciences (OACC) shareholders
Close on Nov 17, 2026Market cap $263.53MP/E –Yield –
Ownership
Who owns Oaktree Acquisition Corp. III Life Sciences's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Oaktree Capital Group Holdings GP, LLC Joint filing with Oaktree Acquisition Holdings III LS, LLC (22.30%), Oaktree Acquisition Holdings III LS GP, Ltd. (22.30%) and 1 more | 5,500,535 | 22.30% | 13G (passive) | Dec 31, 2024 |
| AQR Capital Management Holdings, LLC Joint filing with AQR Capital Management, LLC (7.33%), AQR Arbitrage, LLC (7.33%) | 1,450,750 | 7.33% | 13G (passive) amendment | Mar 31, 2025 |
| Barclays PLC | 1,384,810 | 6.99% | 13G (passive) | Jun 30, 2026 |
| The Goldman Sachs Group, Inc. Joint filing with Goldman Sachs & Co. LLC (6.20%) | 1,228,500 | 6.20% | 13G (passive) | Mar 31, 2026 |
| Decagon Asset Management LLP Joint filing with Benjamin John Durham (5.52%) | 1,091,327 | 5.52% | 13G (passive) | Jun 30, 2026 |
| Steven Patrick Pigott Joint filing with Fort Baker Capital Management LP (5.10%), Fort Baker Capital, LLC (5.10%) | 1,000,000 | 5.10% | 13G (passive) | Mar 31, 2026 |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1 funds held OACC in Q2 2026, 100% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of OACC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Horizon Kinetics SPAC Active ETF | 50,006 | – | $535.56K | 5.31% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| George Arthur Martinez | Chief Financial Officer | – | Oct 29, 2025 |
| Thomas Sweeney | Chief Financial Officer | – | Jun 16, 2025 |
| David A. Berry | Director | – | Oct 22, 2025 |
| Oaktree Acquisition Holdings III LS, LLC | 10% owner | 5,383,739 | Oct 23, 2026 |
| Oaktree Capital Holdings, LLC | 10% owner | 550,000 | Oct 23, 2026 |
| Oaktree Acquisition Holdings III LS GP, Ltd. | 10% owner | – | Oct 23, 2026 |
| Capital Management Lp Oaktree | 10% owner | – | Oct 23, 2026 |
| Oaktree Capital Management GP, LLC | 10% owner | – | Oct 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Oaktree Acquisition Holdings III LS, LLC 10% owner | Oct 23, 2026 | Conversion | +4,798,758 | – | – | 5,382,739 |
| Oaktree Acquisition Holdings III LS, LLC 10% owner | Oct 30, 2024 | Conversion | +33,981 | $10.00 | $339.81K | 583,981 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Oaktree Acquisition Corp. III Life Sciences's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?